Our partner is creating a pipeline of precision oncology treatments aimed at patients with unaddressed mutations across well-established oncology targets.

This critical hire led the pharmacovigilance strategy for a precision oncology company, establishing and managing the safety team while advancing assets through development and regulatory submissions. They played a key role in risk management, compliance, and shaping the safety profile of therapies driven by functional genomics and AI-guided drug discovery.